Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Red Blood Cells Transfusion 1Hematologic Neoplasms 1Anemia 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Erythrocyte Transfusion × Clear all
NCT01237639 2016-10-12

TRIST

Ottawa Hospital Research Institute

Phase 3 Completed
300 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT01502215 2012-12-05

TRISOP

University of Sao Paulo

Phase 3 Completed
198 enrolled

Red Blood Cells Transfusion

NCT01648946 2012-11-06

TRICCOP

Instituto do Cancer do Estado de São Paulo

Phase 3 Unknown
300 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡